Inovio Legal Dispute Threatens Production Of Promising COVID Vaccine
Inovio Pharmaceuticals filed suit against VGXI, a subsidiary of South Korea’s GeneOne Life Sciences, last month, accusing it of not transferring technical details pertaining to manufacturing doses of INO-4800, Inovio’s DNA vaccine compound with promising results against SARS-CoV-2. Inovio details in the lawsuit that VGXI does not possess the capacity to scale up manufacturing, which is essential … Read more